We are live on
!
Find out more
C
Cerebellum Portfolio holdings
AUM
$21.5M
This Fund
S&P 500
This Quarter
Est. Return
+1.87%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$59.7M
AUM Growth
-$18.3M
(-24%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-30.61%
Top 10 Holdings %
Top 10 Hldgs %
3.14%
Holding
576
New
140
Increased
78
Reduced
180
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$347K |
| 2 |
Lam Research
LRCX
|
+$206K |
| 3 |
Stellantis
STLA
|
+$203K |
| 4 |
Nabors Industries
NBR
|
+$203K |
| 5 |
Toll Brothers
TOL
|
+$202K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.4M |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.53M |
| 3 |
MON
Monsanto Co
MON
|
+$283K |
| 4 |
PepsiCo
PEP
|
+$260K |
| 5 |
TWX
Time Warner Inc
TWX
|
+$255K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.13% |
| 2 | Technology | 15.51% |
| 3 | Industrials | 14.6% |
| 4 | Financials | 13.81% |
| 5 | Energy | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Cigna
CI
$76.6B
| – | – |
-1,139
| Closed | -$191K |
|
427
Commercial Metals
CMC
$7.63B
| – | – |
-7,101
| Closed | -$145K |
|
428
CMS Energy
CMS
$23.1B
| – | – |
-4,469
| Closed | -$202K |
|
429
CenterPoint Energy
CNP
$29.1B
| – | – |
-7,029
| Closed | -$193K |
|
430
Cencora
COR
$60.3B
| – | – |
-2,233
| Closed | -$193K |
|
431
Canadian Pacific Kansas City
CP
$82B
| – | – |
-2,280
| Closed | -$80K |
|
432
Capri Holdings
CPRI
$1.77B
| – | – |
-1,998
| Closed | -$124K |
|
433
Carter's
CRI
$1.43B
| – | – |
-1,794
| Closed | -$187K |
|
434
CoStar Group
CSGP
$11.3B
| – | – |
-3,710
| Closed | -$135K |
|
435
Cognizant
CTSH
$21.5B
| – | – |
-1,875
| Closed | -$151K |
|
436
CVS Health
CVS
$137B
| – | – |
-3,013
| Closed | -$187K |
|
437
Dominion Energy
D
$62.5B
| – | – |
-2,784
| Closed | -$188K |
|
438
Delta Air Lines
DAL
$55.9B
| – | – |
-457
| Closed | -$25K |
|
439
Deere & Co
DE
$170B
| – | – |
-1,278
| Closed | -$198K |
|
440
Dover
DOV
$27.2B
| – | – |
-1,515
| Closed | -$120K |
|
441
DaVita
DVA
$15.1B
| – | – |
-2,858
| Closed | -$188K |
|
442
Electronic Arts
EA
$52.4B
| – | – |
-1,068
| Closed | -$129K |
|
443
Encompass Health
EHC
$11.2B
| – | – |
-4,182
| Closed | -$190K |
|
444
Emerson Electric
EMR
$82.9B
| – | – |
-2,682
| Closed | -$183K |
|
445
EOG Resources
EOG
$78B
| – | – |
-1,868
| Closed | -$197K |
|
446
Entergy
ETR
$54.1B
| – | – |
-2,038
| Closed | -$80K |
|
447
Edwards Lifesciences
EW
$47.6B
| – | – |
-4,008
| Closed | -$186K |
|
448
Exelon
EXC
$48.6B
| – | – |
-7,199
| Closed | -$200K |
|
449
Expeditors International
EXPD
$22.9B
| – | – |
-1,968
| Closed | -$125K |
|
450
Expedia Group
EXPE
$31.2B
| – | – |
-1,661
| Closed | -$183K |
|
Similar funds
PCM
JJ
BPI
TCS
AF
SC
IAM
MTB
Cerebellum's Q2 2018 Portfolio in Review
As of Q2 2018, Cerebellum held 576 positions worth $59.7M, down 24% from $78M the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.
Cerebellum withdrew a net $18.3M in Q2 2018, closing 172 positions and reducing 180 holdings. Its most notable exit was Monsanto Co, an estimated $283K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, Cerebellum opened a new position in Amgen worth $167K.
- Cerebellum's largest Q2 2018 buy was Amgen: 1,961 shares worth $167K.
- Cerebellum added most to Keurig Dr Pepper in Q2 2018, an estimated $184K increase.
- Cerebellum's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $9.4M.
- Cerebellum fully exited Monsanto Co in Q2 2018, selling an estimated $283K.
- Cerebellum's ten largest holdings make up 3.1% of its $59.7M portfolio in Q2 2018.
- Cerebellum opened 140 new positions and closed 172 in Q2 2018.
- Cerebellum's portfolio value fell 24% quarter-over-quarter to $59.7M.
Based on Cerebellum's 13F filing for Q2 2018, filed 5 Jul 2018.